CellFE
Enabling life-saving therapies with a unique platform for cell engineering
Alameda, United States
31 employees
Series A
Total: $26.80M
Biotechnology, Health Care
General Information
Alameda, United States
BounceWatch is an independent company data service, not affiliated with CellFE. To contact CellFE, visit cellfebiotech.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does CellFE compare?
A PDF of CellFE and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting CellFE soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United States Market
Biotechnology
About CellFE
Business keywords: Cell engineering, Microfluidics, Biotech, Gene therapies, Crispr/Cas9, mRNA, Plasmid, Gene editing, High throughput technology, Bioprocessing, Cancer therapies, Medical devices
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | $22.00M | 9 |
|
27 Sep 2023 |
| Seed Round | $4.80M | 1 |
|
16 Jan 2020 |
| Non Equity Assistance | Undisclosed | - |
|
01 Sep 2018 |
CellFE Alternatives & Competitors
View All Alternatives
Laser Focus with Relentless Execution
Delivering a cancer-free future
A world in which cell and organ therapies are universally available to patients.
Virica Biotech
FAQ About CellFE
Source: BounceWatch company record for CellFE, https://bouncewatch.com/company/cellfe, updated 25 November 2024. When citing, please name BounceWatch and link this page.
